Neoplasm Clinical Trials
135 clinical trials for Neoplasm across international registries, including 15 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- Multimodal Artificial Intelligence for Detecting the Psychological State of Cancer Patients — RECRUITING
- Dream2Heal: An Adaptive Stepped-care Intervention for Chinese Cancer Survivors With Mild-to-moderate Insomnia — RECRUITING · NA
- A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies — RECRUITING · PHASE1
- Collection of Pharmacokinetic Samples From People With Unanticipated Response, Significant Toxicity or Concern of Future Toxicity — RECRUITING
- Cancer in the Small Developing Island States of the Eastern Caribbean — RECRUITING
- A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma — RECRUITING · PHASE1
- Intratumoral Macrophage Exosomes With Mechanobiological Reprogramming for Advanced Solid Tumors — RECRUITING · PHASE1
- EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study — RECRUITING · NA
- Preoperative Radiation Therapy and Immediate Breast Reconstruction — RECRUITING · NA
- CARE Study: Cancer, Asian Americans, and Relationship Enrichment — RECRUITING · NA
- Evaluation of the Impact of the Clinical Pharmacist in Oral Therapies in Oncology. — RECRUITING · NA
- Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT) — RECRUITING
- Retrospective WGS Study — RECRUITING
- Enhancing Successful Return to Work of Employees With Cancer, by Supporting Employers (MiLES Intervention) — RECRUITING · PHASE2
- The Drug Rediscovery Protocol (DRUP Trial) — RECRUITING · PHASE2
- Digital Psychoeducational Intervention for Young Adults With Fertility Related Distress Following Cancer Diagnosis — NOT_YET_RECRUITING · NA
- Body Composition and Blood-Based Prognostic Markers in Immunotherapy-Treated Metastatic Non-Small Cell Lung Cancer — COMPLETED
- Natural History of and Specimen Banking for People With Tumors of the Central Nervous System — COMPLETED
- Association Between 4D MRI Parameters and the Clinical Characteristics and Prognosis of Major Chronic Diseases — NOT_YET_RECRUITING
- REstoring Metabolic FLEXibility Through Combined Exercise in Breast Cancer Survivors: A Randomized Controlled Trial. — NOT_YET_RECRUITING · NA
- A Study of SGT-53 in Children With Refractory or Recurrent Solid Tumors — SUSPENDED · PHASE1
- A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients — COMPLETED · NA
- Role of the Pharmacist in Detection of Drug Interactions Before Antitumor Treatment Initiation — COMPLETED
- A Phase 2, Multicenter Study of Autologous Tumor Infiltrating Lymphocytes (LN-144/LN-145/LN-145-S1) in Patients with Solid Tumors — OTHER · PHASE2
- Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors — TERMINATED · PHASE1
- Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial — NOT_YET_RECRUITING · NA
- Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors — TERMINATED · PHASE1
- Study of SAR444881 Administered Alone and in Combination With Other Therapeutics in Participants With Advanced Solid Tumors — TERMINATED · PHASE1
- The Role of 5-Aminolevulinic Acid Fluorescence-Guided Surgery in Head and Neck Cancers: a Pilot Trial — TERMINATED · PHASE2
- A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of JNJ-63723283, an Anti-Programmed Cell Death (PD)-1 Monoclonal Antibody, as Monotherapy or in Combination With Erdafitinib in Japanese Participants With Advanced Solid Cancers — COMPLETED · PHASE1
- A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma — COMPLETED · PHASE2
- Effect of Tusamitamab Ravtansine on QTc Interval in Participants With Metastatic Solid Tumors — TERMINATED · PHASE1
- Procalcitonin and Antimicrobial Utilization in Critically Ill Cancer Patients with Sepsis — TERMINATED · NA
- Human ADME Study of [14C]-Ceralasertib (AZD6738) and Absolute Bioavailability of Ceralasertib — NOT_YET_RECRUITING · PHASE1
- The Samsung Medical Center Comprehensive Cancer Center Registry from 2008 to 2023 — COMPLETED
- Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products — COMPLETED
- A Study to Test Different Doses of BI 891065 Alone and in Combination With BI 754091 in Asian Patients With Different Types of Advanced Cancer (Solid Tumours) — COMPLETED · PHASE1
- Crizotinib (Xalkori) Expanded Access Protocol For The Treatment Of Adult Or Pediatric Patients — TERMINATED
- Study of Ridaforolimus (MK-8669) in Participants With Solid Tumors (MK-8669-003)(COMPLETED) — COMPLETED · PHASE1
- Safety, Preliminary Efficacy and PK of Isatuximab (SAR650984) Alone or in Combination With Atezolizumab in Patients With Advanced Malignancies — TERMINATED · PHASE1
- A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors — TERMINATED · PHASE1
- A Dose Escalation and Combination Immunotherapy Study to Evaluate BMS-986226 Alone or in Combination With Nivolumab or Ipilimumab in Patients With Advanced Solid Tumors — TERMINATED · PHASE1
- Study of ADI-PEG 20 in Patients With Advanced Melanoma — COMPLETED · PHASE1
- Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients — COMPLETED · PHASE1
- A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. — COMPLETED · PHASE1
- A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC) — COMPLETED · PHASE1
- A Phase I Trial of HS-10241 in Solid Tumors — COMPLETED · PHASE1
- A Study of SHR6390 in Advanced Solid Tumor Patients — COMPLETED · PHASE1
- Study of Cryotherapy Treatment of Barrett's Esophagus and Early Esophageal Cancer — TERMINATED
- ECI301 and Radiation for Advanced or Metastatic Cancer — TERMINATED · PHASE1
Refine this search